Nusret Akyürek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nusret Akyürek has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Bülent Salman
Medical School of Gazi University, Department of General Surgery, HPB Surgery Unit Ankara Turkey
2 shared publications- Abdülkadir Bedirli
Department of General Surgery, Gazi University School of Medicine, Ankara, Turkey
1 shared publication - Abdülkadir Bülent Aytaç
Department of General Surgery Bandirma Training and Research Hospital Balikesir Türkiye
1 shared publication - Ahmet Karamercan
Department of General Surgery, Faculty of Medicine, Gazi University, Ankara, Turkey
1 shared publication - Aydın Dalgıç
Faculty of Medicine, Department of General Surgery, Gazi University, Ankara, Turkey
1 shared publication - Aydın Yavuz
Department of General Surgery, Gazi University Faculty of Medicine, Ankara, Turkey
1 shared publication
Latest Publications
- 24 October 2024
- Published by Academician Publishing
- p. 107-114
Morbid Obesity Surgery and Postgastrectomy Syndromes
- 24 October 2024
- Published by Academician Publishing
- p. 107-114
Morbid Obesity Surgery and Postgastrectomy Syndromes
- 24 October 2024
- Published by Academician Publishing
Open AccessGeneral Surgery - Oral Exam Questions
- Open Access
- 4 September 2024
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 24 (1) , 1-6
Investigation of pre and postoperative Th1/Th2 cytokine balance and novel cytokines in colorectal cancer patients
Colorectal cancer (CRC) is a major health problem worldwide and is usually detected in advanced stages, although it is highly treatable with early detection. The aim of this study was to examine the serum levels of various cytokines involved in the pathogenesis of CRC. The study included 29 patients and 30 healthy volunteers. Blood samples were collected twice from the patient group, before and after surgery, and these samples were evaluated for interleukin (IL) 4, 10, 23r, 37, 38, 40 and interferon (IFN) gamma levels. The results showed that IL-4 and IL-38 levels were significantly lower in the preoperative serum samples of the patient group compared to the control group (p < 0.001 and p = 0.01, respectively), while IL-4, IL-10, IL-38 and IL-40 levels increased significantly in the postoperative period (p = 0.004, p = 0.02, p = 0.03 and p = 0.004, respectively). These findings may contribute to the development of immunotherapy agents in the treatment of CRC. However, comprehensive studies on larger patient groups are needed to fully understand the role of cytokines in CRC pathogenesis.
- 4 September 2024
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 24 (1) , 1-6
Open AccessInvestigation of pre and postoperative Th1/Th2 cytokine balance and novel cytokines in colorectal cancer patients
Colorectal cancer (CRC) is a major health problem worldwide and is usually detected in advanced stages, although it is highly treatable with early detection. The aim of this study was to examine the serum levels of various cytokines involved in the pathogenesis of CRC. The study included 29 patients and 30 healthy volunteers. Blood samples were collected twice from the patient group, before and after surgery, and these samples were evaluated for interleukin (IL) 4, 10, 23r, 37, 38, 40 and interferon (IFN) gamma levels. The results showed that IL-4 and IL-38 levels were significantly lower in the preoperative serum samples of the patient group compared to the control group (p < 0.001 and p = 0.01, respectively), while IL-4, IL-10, IL-38 and IL-40 levels increased significantly in the postoperative period (p = 0.004, p = 0.02, p = 0.03 and p = 0.004, respectively). These findings may contribute to the development of immunotherapy agents in the treatment of CRC. However, comprehensive studies on larger patient groups are needed to fully understand the role of cytokines in CRC pathogenesis.
- Open Access
- 5 April 2021
- Published by Academician Publishing
- p. 85-91
Morbid Obezite Cerrahisi ve Postgastrektomi Sendromları
- 5 April 2021
- Published by Academician Publishing
- p. 85-91
Open AccessMorbid Obezite Cerrahisi ve Postgastrektomi Sendromları
Ultrasonography in the diagnosis of true gallbladder polyps: the contradiction in the literature
Polypoid lesions of the gallbladder (PLGs) are defined as masses protruding from the mucosal surface of the gallbladder. These lesions, as reported in the literature, range from 1.3% to 6.9% in both genders 1 x [1] Jorgensen, T. and Jensen, K.H. Polyps in the gallbladder: a prevalence study. Scand J Gastroenterol. 1990; 25: 281–286 PubMed | Google Scholar See all References , 2 x [2] Chen, C.Y., Lu, C.L., Chang, F.Y., and Lee, S.D. Risk factors for gallbladder polyps in the Chinese population. Am J Gastroenterol. 1997; 92: 2066–2068 PubMed | Google Scholar See all References , 3 x [3] Ozmen, M.M., Patankar, R.V., Hengirmen, S., and Terzi, M.C. Epidemiology of gallbladder polyps. Scand J Gastroenterol. 1994; 29: 480 Crossref | PubMed | Scopus (16) | Google Scholar See all References . PLGs can be benign or malignant. In 1958, Carrera and Oschsner 4 x [4] Carrera, G.M. and Oschsner, S.F. Polypoid mucosal lesions of gallbladder. JAMA. 1958; 166: 888–892 Crossref | PubMed | Scopus (13) | Google Scholar See all References 4 evaluated polyps taken from more than 1300 cholecystectomies and described five types of mucosal polypoid lesions: inflammatory, cholesterol, adenoma, adenomyoma, and carcinoma. In 1970, Christensen and Ihsak 5 x [5] Christensen, A.H. and Ihsak, K.G. Benign tumors and pseudotumors of the gallbladder. Arch Pathol. 1970; 90: 423–432 PubMed | Google Scholar See all References 5 evaluated 180 gallbladder lesions at the Armed Forces Institute of Pathology. In addition to the categories described by Carrera and Oschsner, they also noted two granular cell tumors of the cystic duct and seven polyps of gastric heterotopic tissue. PLGs are usually diagnosed with ultrasonography (US) as nonshadowing, fixed, solid masses. Symptoms are unusual unless other abnormalities, such as stones, are present. The widespread use of US in patients with suspected gallstones and screening for other abdominal diseases has increased the detection rate of PLGs. Once identified, they pose a dilemma with respect to their proper long‐term management 6 x [6] Rosin, R.D. Laparoscopic cholecystectomy. in: Zinner M.J., Schwartz S., Ellis H. (Eds.) Maingot's abdominal operations. Appleton & Lange, ; 1997: 1864–1865 Google Scholar See all References 6 . Physicians interpreting US reports describing PLGs must understand the accuracy and significance of this US finding, as it could affect the determination of the necessity for cholecystectomy. The present retrospective study was designed to determine the reliability of US in the diagnosis of PLGs. The literature was also reviewed for current diagnostic modalities for PLGs.
Ultrasonography in the diagnosis of true gallbladder polyps: the contradiction in the literature
Polypoid lesions of the gallbladder (PLGs) are defined as masses protruding from the mucosal surface of the gallbladder. These lesions, as reported in the literature, range from 1.3% to 6.9% in both genders 1 x [1] Jorgensen, T. and Jensen, K.H. Polyps in the gallbladder: a prevalence study. Scand J Gastroenterol. 1990; 25: 281–286 PubMed | Google Scholar See all References , 2 x [2] Chen, C.Y., Lu, C.L., Chang, F.Y., and Lee, S.D. Risk factors for gallbladder polyps in the Chinese population. Am J Gastroenterol. 1997; 92: 2066–2068 PubMed | Google Scholar See all References , 3 x [3] Ozmen, M.M., Patankar, R.V., Hengirmen, S., and Terzi, M.C. Epidemiology of gallbladder polyps. Scand J Gastroenterol. 1994; 29: 480 Crossref | PubMed | Scopus (16) | Google Scholar See all References . PLGs can be benign or malignant. In 1958, Carrera and Oschsner 4 x [4] Carrera, G.M. and Oschsner, S.F. Polypoid mucosal lesions of gallbladder. JAMA. 1958; 166: 888–892 Crossref | PubMed | Scopus (13) | Google Scholar See all References 4 evaluated polyps taken from more than 1300 cholecystectomies and described five types of mucosal polypoid lesions: inflammatory, cholesterol, adenoma, adenomyoma, and carcinoma. In 1970, Christensen and Ihsak 5 x [5] Christensen, A.H. and Ihsak, K.G. Benign tumors and pseudotumors of the gallbladder. Arch Pathol. 1970; 90: 423–432 PubMed | Google Scholar See all References 5 evaluated 180 gallbladder lesions at the Armed Forces Institute of Pathology. In addition to the categories described by Carrera and Oschsner, they also noted two granular cell tumors of the cystic duct and seven polyps of gastric heterotopic tissue. PLGs are usually diagnosed with ultrasonography (US) as nonshadowing, fixed, solid masses. Symptoms are unusual unless other abnormalities, such as stones, are present. The widespread use of US in patients with suspected gallstones and screening for other abdominal diseases has increased the detection rate of PLGs. Once identified, they pose a dilemma with respect to their proper long‐term management 6 x [6] Rosin, R.D. Laparoscopic cholecystectomy. in: Zinner M.J., Schwartz S., Ellis H. (Eds.) Maingot's abdominal operations. Appleton & Lange, ; 1997: 1864–1865 Google Scholar See all References 6 . Physicians interpreting US reports describing PLGs must understand the accuracy and significance of this US finding, as it could affect the determination of the necessity for cholecystectomy. The present retrospective study was designed to determine the reliability of US in the diagnosis of PLGs. The literature was also reviewed for current diagnostic modalities for PLGs.
- 1 January 2005
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 18 (5) , 247-256
The Effect of Platelet Activating Factor Antagonist BN 52021 on Bacterial Translocation and ICAM-I Expression in Experimental Obstructive Jaundice
Expression of intracellular adhesion molecule-1 (ICAM-1) in an obstructive jaundice model and the potential protective role of platelet activating factor antagonist over small intestine and liver together with its effects on bacterial translocation are examined in this study. Forty-eight male Wistar albino rats were assigned into four equal groups of 12. In groups I and II, animals were sham operated. In groups III and IV, common bile duct ligation and division were performed. In group I and group III, 0.5 ml/day normal saline was applied intraperitoneally daily from day 2 to 6 of the study; in group II and group IV, 1 mg/kg/day BN 52021 was applied intraperitoneally daily from day 2 to 6 of the study. All animals were sacrificed on postoperative day 7. ICAM-1 expression (CD54 positivity) was analyzed in the liver and ileum tissue by immunohistochemical method. Samples from blood, liver mesenteric lymph nodes, and spleen were cultured under aerobic conditions. It is revealed that ICAM-1 expression was statistically higher in group III, with highest bacterial translocation and liver and spleen injury when compared to other groups. Serum alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), gamma-glutamyltranspeptidase (GGT), bilirubin, tumor necrosis factor alpha (TNFalpha), and interleukin 1beta(IL-1beta) values were at the highest level in group III, and there was a statistical decrease in group IV compared to group III. The administration of BN52021 in experimental obstructive jaundice is a useful way to reduce liver and intestinal mucosal villi damage by inhibiting bacterial translocation and systemic inflammatory response.
- 1 January 2005
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 18 (5) , 247-256
The Effect of Platelet Activating Factor Antagonist BN 52021 on Bacterial Translocation and ICAM-I Expression in Experimental Obstructive Jaundice
Expression of intracellular adhesion molecule-1 (ICAM-1) in an obstructive jaundice model and the potential protective role of platelet activating factor antagonist over small intestine and liver together with its effects on bacterial translocation are examined in this study. Forty-eight male Wistar albino rats were assigned into four equal groups of 12. In groups I and II, animals were sham operated. In groups III and IV, common bile duct ligation and division were performed. In group I and group III, 0.5 ml/day normal saline was applied intraperitoneally daily from day 2 to 6 of the study; in group II and group IV, 1 mg/kg/day BN 52021 was applied intraperitoneally daily from day 2 to 6 of the study. All animals were sacrificed on postoperative day 7. ICAM-1 expression (CD54 positivity) was analyzed in the liver and ileum tissue by immunohistochemical method. Samples from blood, liver mesenteric lymph nodes, and spleen were cultured under aerobic conditions. It is revealed that ICAM-1 expression was statistically higher in group III, with highest bacterial translocation and liver and spleen injury when compared to other groups. Serum alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), gamma-glutamyltranspeptidase (GGT), bilirubin, tumor necrosis factor alpha (TNFalpha), and interleukin 1beta(IL-1beta) values were at the highest level in group III, and there was a statistical decrease in group IV compared to group III. The administration of BN52021 in experimental obstructive jaundice is a useful way to reduce liver and intestinal mucosal villi damage by inhibiting bacterial translocation and systemic inflammatory response.